Abstract
A calculation grid developed by an international expert group was tested across biobanks in six countries to evaluate costs for collections of various types of biospecimens. The assessment yielded a tool for setting specimen-access prices that were transparently related to biobank costs, and the tool was applied across three models of collaborative partnership.
Original language | English |
---|---|
Pages (from-to) | 261 |
Journal | Science Translational Medicine |
Volume | 6 |
DOIs | |
Publication status | Published - 2014 |